Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$7.32-0.68%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · MRVI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 208.8 | 185.7 | 259.2 | 288.9 | 883.0 | 799.2 | 284.1 |
| Cost of Revenues | 135.9 | 151.8 | 150.9 | 148.7 | 169.0 | 140.6 | 79.6 |
| Gross Profit | 72.8 | 34.0 | — | 140.2 | — | — | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 128.0 | 145.1 | 161.8 | 151.4 | 129.3 | 100.1 | 94.2 |
| R&D Expenses | 15.2 | 17.4 | 19.2 | 17.3 | 18.4 | 15.2 | 9.3 |
| Operating Income | (117.1) | (215.3) | (235.6) | (31.6) | 574.2 | 554.6 | 119.9 |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 27.0 | 47.7 | 45.9 | 20.4 | 30.3 | 30.7 |
| Interest & Investment Income | 8.2 | 11.4 | 27.4 | 27.7 | 2.3 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | 18.2 | 18.1 | 30.3 | 30.7 |
| Asset Writedown | — | 84.6 | — | 0.0 | — | — | — |
| EBT, Incl. Unusual Items | (136.5) | (235.0) | (261.5) | 617.7 | 551.5 | 530.8 | 81.7 |
| Income Tax Expense | (0.4) | (4.2) | (1.9) | 756.1 | 60.8 | 61.5 | 2.9 |
| Net Income | |||||||
| Minority Interest | (58.7) | (100.0) | (114.8) | (19.3) | 270.5 | 287.2 | (10.2) |
| Net Income | (77.4) | (130.8) | (144.8) | (138.4) | 490.7 | 469.3 | 89.0 |
| Per Share | |||||||
| Basic EPS | (0.52) | (0.90) | (1.05) | (0.90) | 1.67 | 1.59 | 7.43 |
| Diluted EPS | (0.52) | (0.90) | (1.05) | (0.90) | 1.67 | 1.56 | 2.36 |
| Revenue per Share | 1.41 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 148.0 | 144.4 | 137.9 | 131.9 | 131.5 | 114.8 | 10.4 |
| Diluted Weighted Avg Shares | 148.0 | 144.4 | 137.9 | 131.9 | 255.3 | 257.8 | 28.9 |
| Supplemental | |||||||
| EBIT | (117.1) | (215.3) | (235.6) | (31.6) | 574.2 | 554.6 | 119.9 |
| Effective Tax Rate | 0.3% | — | — | 122.4% | 11.0% | 11.6% | 3.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.